semaglutide strips Sem-P (Semaglutide) 4mg/3ml FDA ends shortage of popular
Description
Retatrutide's triple-receptor mechanism means its full safety profile is still being characterised through ongoing clinical trials, and vigilance is particularly important during this period
Zhao, and S
Its longer half-life reduces the frequency of injections needed, improving patient compliance
The only caveats: its medications are compounded and not FDA-approved, labs are not standard at the start, and the brand is young with limited third-party reviews
Times of India
